Page last updated: 2024-10-30

maprotiline and Purpura, Thrombocytopenic, Idiopathic

maprotiline has been researched along with Purpura, Thrombocytopenic, Idiopathic in 1 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Purpura, Thrombocytopenic, Idiopathic: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
König, F1
Stumpp, W1
Wolfersdorf, M1
Leibfarth, M1
Fuchs, G1
Kaschka, WP1

Other Studies

1 other study available for maprotiline and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
[Follow-up of Werlhof disease after onset of treatment with maprotiline].
    Der Nervenarzt, 1995, Volume: 66, Issue:1

    Topics: Amitriptyline; Cilazapril; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Comb

1995